Univariable analyses | Multivariable analyses | |||
---|---|---|---|---|
HR (95% CI) | p a | HR (95% CI) | p b | |
Age (years) | 0.005 | 0.301 | ||
≤ 55 | 1 (Ref) | 1 (Ref) | ||
> 55 | 1.180 (1.052–1.322) | 0.005 | 1.066 (0.944–1.204) | 0.301 |
Sex | 0.801 | 0.937 | ||
Women | 1 (Ref) | 1 (Ref) | ||
Men | 1.016 (0.897–1.151) | 0.801 | 0.995 (0.872–1.135) | 0.937 |
Tumor size | 0.000 | 0.000 | ||
≤ 4 cm | 1 (Ref) | 1 (Ref) | ||
5–8 cm | 2.101 (1.848–2.389) | 0.000 | 1.256 (1.091–1.446) | 0.001 |
≥ 9 cm | 3.694 (3.152–4.328) | 0.000 | 1.372 (1.117–1.686) | 0.003 |
Tumour site | 0.000 | 0.000 | ||
Whole stomach | 1 (Ref) | 1 (Ref) | ||
Upper stomach | 0.499 (0.399–0.624) | 0.000 | 1.097 (0.828–1.453) | 0.519 |
Middle stomach | 0.324 (0.253–0.415) | 0.000 | 0.919 (0.691–1.223) | 0.562 |
Lower stomach | 0.316 (0.263–0.379) | 0.000 | 0.749 (0.5814–0.966) | 0.026 |
> 2/3 stomach | 0.512 (0.420–0.623) | 0.000 | 0.774 (0.6110–0.979) | 0.033 |
Gross appearance | 0.000 | 0.000 | ||
Borrmann types I | 1 (Ref) | 1 (Ref) | ||
Borrmann types II | 0.553 (0.331–0.924) | 0.024 | 0.562 (0.331–0.954) | 0.033 |
Borrmann types III | 0.864 (0.527–1.417) | 0.563 | 0.833 (0.498–1.392) | 0.485 |
Borrmann types IV | 1.856 (1.116–3.087) | 0.017 | 0.970 (0.571–1.648) | 0.911 |
Tumour stage | 0.000 | 0.002 | ||
T1 | 1 (Ref) | 1 (Ref) | ||
T2 | 8.192 (5.560–12.069) | 0.000 | 3.897 (1.716–8.850) | 0.001 |
T3 | 15.017 (10.151–22.216) | 0.000 | 4.409 (1.894–10.262) | 0.001 |
T4a | 21.388 (14.039–32.585) | 0.000 | 5.901 (2.433–14.317) | 0.000 |
T4b | 31.140 (20.876–46.452) | 0.000 | 5.720 (2.382–13.734) | 0.000 |
Lymph-node stage | 0.000 | 0.003 | ||
N0 | 1 (Ref) | 1 (Ref) | ||
N1 | 1.710 (1.443–2.026) | 0.000 | 1.042 (0.839–1.294) | 0.710 |
N2 | 2.163 (1.847–2.535) | 0.000 | 1.061 (0.831–1.354) | 0.636 |
N3 | 3.462 (2.976–4.027) | 0.000 | 1.462 (1.122–1.905) | 0.005 |
TNM stage | 0.000 | 0.000 | ||
IA | 1 (Ref) | 1 (Ref) | ||
IB | 5.046 (3.140–8.110) | 0.000 | 1.095 (0.402–2.984) | 0.859 |
IIA | 7.889 (4.966–12.531) | 0.000 | 1.397 (0.503–3.881) | 0.521 |
IIB | 11.514 (7.265–18.250) | 0.000 | 1.709 (0.594–4.913) | 0.320 |
IIIA | 15.752 (9.982–24.857) | 0.000 | 1.830 (0.627–5.337) | 0.269 |
IIIB | 18.880 (11.853–30.074) | 0.000 | 1.775 (0.595–5.296) | 0.304 |
IIIC | 34.931 (21.597–56.497) | 0.000 | 2.016 (0.641–6.346) | 0.231 |
IV | 45.506 (28.699–72.155) | 0.000 | 1.593 (0.455–5.580) | 0.467 |
Surgery | 0.000 | 0.000 | ||
Absolutely curative | 1 (Ref) | 1 (Ref) | ||
Relatively curative | 2.025 (1.763–2.325) | 0.000 | 1.203 (1.030–1.406) | 0.020 |
Palliative | 5.815 (5.051–6.693) | 0.000 | 2.422 (1.755–3.341) | 0.000 |
Lymph node dissection | 0.000 | 0.150 | ||
D1 | 1 (Ref) | 1 (Ref) | ||
D2 | 0.867 (0.711–1.058) | 0.161 | 0.815 (0.652–1.019) | 0.072 |
D3 | 0.839 (0.639–1.101) | 0.206 | 0.830 (0.615–1.119) | 0.221 |
Palliative resection | 3.323 (2.687–4.111) | 0.000 | 0.677 (0.502–0.914) | 0.011 |
Joint organ removal | 0.000 | 0.020 | ||
None | 1 (Ref) | 1 (Ref) | ||
Pancreas or spleen | 2.125 (1.744–2.590) | 0.000 | 1.229 (0.972–1.553) | 0.085 |
Liver or gall | 1.722 (1.291–2.296) | 0.000 | 1.093 (0.773–1.546) | 0.615 |
Transverse colon | 2.227 (1.879–2.641) | 0.000 | 1.300 (1.061–1.593) | 0.011 |
Other | 2.907 (2.206–3.830) | 0.000 | 1.278 (0.947–1.724) | 0.109 |
Gastrectomy | 0.000 | 0.603 | ||
Total | 1 (Ref) | 1 (Ref) | ||
Subtotal | 0.522 (0.457–0.596) | 0.000 | 1.050 (0.874–1.261) | 0.603 |
Hepatic metastasis | 0.000 | 0.037 | ||
No | 1 (Ref) | 1 (Ref) | ||
Yes | 4.548 (3.555–5.818) | 0.000 | 1.769 (1.035–3.023) | 0.037 |
Peritoneum metastasis | 0.000 | 0.004 | ||
No | 1 (Ref) | 1 (Ref) | ||
Yes | 4.190 (3.547–4.948) | 0.000 | 1.525 (0.837–2.780) | 0.168 |
Adjunctive therapy | 0.000 | 0.001 | ||
No | 1 (Ref) | 1 (Ref) | ||
Yes | 0.720 (0.612–0.846) | 0.000 | 0.766 (0.638–0.919) | 0.004 |
Diagnosis period | 0.004 | 0.023 | ||
1980s | 1 (Ref) | 1 (Ref) | ||
1990s | 0.948 (0.817–1.100) | 0.479 | 0.903 (0.767–1.063) | 0.220 |
2000s | 0.823 (0.714–0.948) | 0.007 | 0.846 (0.702–1.020) | 0.080 |